Topline Data from 52-week Phase 3 Study Expected in Late 2025 –CAMBRIDGE, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, ...
INZ-701 was well-tolerated and significantly increased plasma pyrophosphate (PPi) levels in patients with end-stage kidney disease (ESKD) ...
“Grim is a good word to explain this site. It just looks like in it’s in a mess,” Ms Rotheray said. "It looks like it’s been ...
A study from Johns Hopkins Medicine reveals that men with low-risk prostate cancer may reduce their progression risk by ...
A staggering 56 per cent of surveyed women had minimal formal education, attending school for less than five years. This low baseline knowledge makes it difficult for them to understand the ...
DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing blood sugar groups KELOWNA, BC / ACCESSWIRE / October 24, 2024 / Lexaria Bioscience Corp.
Advances in Therapy to Address Proteinuria in Patients with Immunoglobulin A Nephropathy. As the majority of patients with ...
The data presented indicate a favorable gut bile acid profile which may contribute to ibezapostat's beneficial anti-recurrence effect in patients with C. difficile Infection (CDI)Ibezapolstat ...
Pakistan's information technology exports maintained their growth as they fetched $292 million in September 2024, up 42% from the same month of last year and higher than the last 12-month average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback